Panelists discuss how the rapid adoption of subcutaneous (SubQ) oncology therapies creates challenges around clinical autonomy, infusion center sustainability, patient experience, and reimbursement ...

Panelists discuss how subcutaneous (SubQ) oncology treatments are reshaping clinic operations by improving infusion chair utilization, enabling flexible scheduling, streamlining pharmacy workflows ...

Courtney R. Marr 1,2,a, Julia E. McSweeney 1,2,a, Mary P. Mullen 1, Thomas J. Kulik 1, Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric ...

OCARINA II randomized 236 MS patients to 920 mg subcutaneous injection (118 participants) or 600 mg IV infusion (118 participants). Infusions were administered at 300 mg at two IV sessions, 2 ...

Compared with oral administration, continuous subcutaneous infusion of carbidopa/levodopa was linked to nearly 2 more hours of “on” time without dyskinesia in adults with Parkinson’s disease ...

KORU Medical Systems, Inc. KRMD has made a strategic move in its pursuit of expanding its footprint in the realm of large-volume subcutaneous infusion. The company announced a collaboration with a ...